Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

CyberKnife Robotic Radiosurgery System passes the 4,000 patients milestone

Accuray : 16 November, 2007  (New Product)
Accuray’s CyberKnife Robotic Radiosurgery System has now treated more than 4,000 lung cancer patients worldwide.
The company also reported that more than 40,000 patients in total have been treated with CyberKnife Radiosurgery for tumours throughout the body.

In April 2007, Accuray announced that the number of lung tumor patients treated with the CyberKnife System had surpassed 2,000. In the span of seven months, that number doubled, demonstrating the growing clinical adoption of this treatment modality in lung cancer care.

This significant growth is due in part to the increasing availability of Accuray’s unparalleled lung cancer treatment offerings at CyberKnife centres. These one-of-a-kind offerings include the Synchrony Respiratory Tracking System, which continuously synchronises radiation beam delivery with the motion of the tumour, and the Xsight Lung Tracking System, which uses the body’s internal anatomy to precisely track lung tumours non-invasively. It is expected that this number will continue to increase significantly with the launch of M D Anderson’s prospective clinical lung study, which Accuray announced last month.

According to the American Cancer Society (ACS), lung cancer is the leading cause of cancer-related deaths in the United States and will account for approximately 29 percent of all cancer deaths in 2007. The ACS projects that more than 213,000 new cases of lung cancer will be discovered this year, accounting for 15 percent of all cancer diagnoses.

“In cancer care, the paradigm is shifting toward less invasive treatment alternatives that exhibit fewer risks, fewer side effects and decreased recovery times,” said Euan S Thomson, PhD, president and CEO of Accuray. “The rapid increase in lung cancer patients treated with our System proves that this is a reality. More and more patients are opting for CyberKnife Radiosurgery as a non-invasive means of treating their cancer and maintaining their quality of life.”
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo